Makers Artesunate 60 Injection contains Artesunate 60 mg, a potent antimalarial agent derived from artemisinin, used primarily for the treatment of severe malaria caused by Plasmodium falciparum. Artesunate acts rapidly by generating reactive oxygen species that damage parasitic proteins and membranes, leading to swift parasite clearance from the bloodstream. This injectable formulation is indicated for use in patients with complicated or severe malaria where oral administration is not feasible or effective. It is administered intravenously or intramuscularly, ensuring rapid bioavailability and prompt therapeutic action. The drug is particularly valuable in reducing mortality and morbidity associated with cerebral malaria and other severe manifestations. Dosage and duration of treatment should be guided by clinical response and severity of infection, typically followed by a full course of oral antimalarials to prevent recrudescence. Caution is advised in patients with known hypersensitivity to artesunate or related compounds. Adverse effects are generally mild but may include transient gastrointestinal disturbances, dizziness, or injection site reactions. Makers Artesunate 60 Injection should be used under strict medical supervision with appropriate monitoring to optimize efficacy and safety in the management of severe malaria.